SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-047363
Filing Date
2021-09-08
Accepted
2021-09-08 16:31:41
Documents
66
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tnya-10q_20210630.htm   iXBRL 10-Q 5179084
2 EX-31.1 tnya-ex311_48.htm EX-31.1 21801
3 EX-31.2 tnya-ex312_47.htm EX-31.2 22109
4 EX-32.1 tnya-ex321_46.htm EX-32.1 15485
  Complete submission text file 0001564590-21-047363.txt   10893709

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tnya-20210630.xsd EX-101.SCH 52351
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnya-20210630_cal.xml EX-101.CAL 48305
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnya-20210630_def.xml EX-101.DEF 205959
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnya-20210630_lab.xml EX-101.LAB 399237
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnya-20210630_pre.xml EX-101.PRE 322478
10 EXTRACTED XBRL INSTANCE DOCUMENT tnya-10q_20210630_htm.xml XML 1327046
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40656 | Film No.: 211242451
SIC: 2836 Biological Products, (No Diagnostic Substances)